Pathogenic Advances and Therapeutic Perspectives for Eosinophilic Inflammation
With the recent approval of the first eosinophil-depleting therapeutic agents targeting the IL-5 pathway for treatment of severe eosinophilic asthma, eosinophils and eosinophilic disorders are in the limelight. Indeed, setbacks during clinical development of these compounds have revealed how much re...
Saved in:
| Superior document: | Frontiers Research Topics |
|---|---|
| : | |
| Year of Publication: | 2018 |
| Language: | English |
| Series: | Frontiers Research Topics
|
| Physical Description: | 1 electronic resource (279 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|